Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Titel:
Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial
Auteur:
Li, Feng-fei Jiang, Lanlan Fu, Liyuan Zhu, Hong-hong Zhou, Peihua Zhang, Danfeng Su, Xiao-fei Wu, Jin-dan Ye, Lei Ma, Jian-hua